In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services.
CITATION STYLE
Drost, S. A., Rajakumar, I., & Rennert-May, E. (2023). Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients. Antimicrobial Stewardship and Healthcare Epidemiology, 3(1). https://doi.org/10.1017/ash.2023.133
Mendeley helps you to discover research relevant for your work.